Market Executive Summary
Gene therapy is an experimental treatment that involves introducing genetic material into a person’s cells to fight or prevent disease. Researchers are studying gene therapy for a number of diseases, such as severe combined immuno-deficiencies, hemophilia, Parkinson's disease, cancer and even HIV, through a number of different approaches. A gene can be delivered to a cell using a carrier known as a “vector.” The most common types of vectors used in gene therapy are viruses. The viruses used in gene therapy are altered to make them safe, although some risks still exist with gene therapy. The technology is still in its infancy.
Due to the COVID-19 pandemic, the global Gene Therapy market size was US$ 7077.6 million in 2022 and is forecast to a readjusted size of US$ 39700 million by 2029 with a CAGR of 27.6% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Viral Gene Therapy accounting for % of the Gene Therapy global market in 2022, is projected to value US$ million by 2029, growing at a revised ?GR from 2023 to 2029. While Neurological Diseases segment is altered to an ?GR throughout this forecast period.
Global Gene Therapy key players include Biogen, Novartis, Gilead Sciences, etc. Global top three manufacturers hold a share about 75%.
North America is the largest market, with a share about 60%, followed by Europe and Asia-Pacific, both have a share about 35 percent.
In terms of product, Non-viral Gene Therapy is the largest segment, with a share about 55%. And in terms of application, the largest application is Neurological Diseases, followed by Cancer.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Gene Therapy market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Gene Therapy market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Gene Therapy market. Readers of the report can become informed about current and future trends of the global Gene Therapy market and how they will impact market growth during the forecast period.
By Company
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
Segment by Type
Viral Gene Therapy
Non-Viral Gene Therapy
Segment by Application
Neurological Diseases
Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on.
Chapter 2: Revenue of Gene Therapy in global and regional level.
Chapter 3: Detailed analysis of Gene Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by region, revenue for each segment.
Chapter 9: Latin America by type, by application and by country, revenue for each segment.
Chapter 10: Middle East and Africa, by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 13: Research Findings and Conclusion
Related Report:
Global Advanced Cell Therapies Market Analysis, Share, Opportunities, Growth Trends and Forecast 2023-2030
Global T-Cell Therapy Market Analysis, Share, Opportunities, Growth Trends and Forecast 2023-2030
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Viral Gene Therapy
1.2.3 Non-Viral Gene Therapy
1.3 Market by Application
1.3.1 Global Gene Therapy Market Growth Rate by Application: 2018 VS 2022 VS 2029
1.3.2 Neurological Diseases
1.3.3 Cancer
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Market Perspective
2.1 Global Gene Therapy Market Size (2018-2029)
2.2 Gene Therapy Market Size across Key Geographies Worldwide: 2018 VS 2022 VS 2029
2.3 Global Gene Therapy Market Size by Region (2018-2023)
2.4 Global Gene Therapy Market Size Forecast by Region (2024-2029)
2.5 Global Top 10 Gene Therapy Countries Ranking by Market Size
3 Gene Therapy Competitive by Company
3.1 Global Gene Therapy Revenue by Players
3.1.1 Global Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Gene Therapy Market Share by Players (2018-2023)
3.2 Global Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Gene Therapy Revenue
3.4 Global Gene Therapy Market Concentration Ratio
3.4.1 Global Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Revenue in 2022
3.5 Global Key Players of Gene Therapy Head office and Area Served
3.6 Global Key Players of Gene Therapy, Product and Application
3.7 Global Key Players of Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Gene Therapy Breakdown Data by Type
4.1 Global Gene Therapy Historic Revenue by Type (2018-2023)
4.2 Global Gene Therapy Forecasted Revenue by Type (2024-2029)
5 Global Gene Therapy Breakdown Data by Application
5.1 Global Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gene Therapy Revenue by Company (2021-2023)
6.2 North America Gene Therapy Revenue by Type (2018-2029)
6.3 North America Gene Therapy Revenue by Application (2018-2029)
6.4 North America Gene Therapy Revenue by Country (2018-2029)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Gene Therapy Revenue by Company (2021-2023)
7.2 Europe Gene Therapy Revenue by Type (2018-2029)
7.3 Europe Gene Therapy Revenue by Application (2018-2029)
7.4 Europe Gene Therapy Revenue by Country (2018-2029)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Gene Therapy Revenue by Company (2021-2023)
8.2 Asia Pacific Gene Therapy Revenue by Type (2018-2029)
8.3 Asia Pacific Gene Therapy Revenue by Application (2018-2029)
8.4 Asia Pacific Gene Therapy Revenue by Region (2018-2029)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 China Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
9 Latin America
9.1 Latin America Gene Therapy Revenue by Company (2021-2023)
9.2 Latin America Gene Therapy Revenue by Type (2018-2029)
9.3 Latin America Gene Therapy Revenue by Application (2018-2029)
9.4 Latin America Gene Therapy Revenue by Country (2018-2029)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Gene Therapy Revenue by Company (2021-2023)
10.2 Middle East and Africa Gene Therapy Revenue by Type (2018-2029)
10.3 Middle East and Africa Gene Therapy Revenue by Application (2018-2029)
10.4 Middle East and Africa Gene Therapy Revenue by Country (2018-2029)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
11 Company Profiles
11.1 Biogen
11.1.1 Biogen Company Details
11.1.2 Biogen Business Overview
11.1.3 Biogen Gene Therapy Products and Services
11.1.4 Biogen Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.1.5 Biogen Gene Therapy SWOT Analysis
11.1.6 Biogen Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Gene Therapy Products and Services
11.2.4 Novartis Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.2.5 Novartis Gene Therapy SWOT Analysis
11.2.6 Novartis Recent Development
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Details
11.3.2 Gilead Sciences Business Overview
11.3.3 Gilead Sciences Gene Therapy Products and Services
11.3.4 Gilead Sciences Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.3.5 Gilead Sciences Gene Therapy SWOT Analysis
11.3.6 Gilead Sciences Recent Development
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Details
11.4.2 Sarepta Therapeutics Business Overview
11.4.3 Sarepta Therapeutics Gene Therapy Products and Services
11.4.4 Sarepta Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.4.5 Sarepta Therapeutics Gene Therapy SWOT Analysis
11.4.6 Sarepta Therapeutics Recent Development
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Details
11.5.2 Alnylam Pharmaceuticals Business Overview
11.5.3 Alnylam Pharmaceuticals Gene Therapy Products and Services
11.5.4 Alnylam Pharmaceuticals Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.5.5 Alnylam Pharmaceuticals Gene Therapy SWOT Analysis
11.5.6 Alnylam Pharmaceuticals Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Amgen Business Overview
11.6.3 Amgen Gene Therapy Products and Services
11.6.4 Amgen Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.6.5 Amgen Gene Therapy SWOT Analysis
11.6.6 Amgen Recent Development
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Details
11.7.2 Spark Therapeutics Business Overview
11.7.3 Spark Therapeutics Gene Therapy Products and Services
11.7.4 Spark Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.7.5 Spark Therapeutics Gene Therapy SWOT Analysis
11.7.6 Spark Therapeutics Recent Development
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Details
11.8.2 Akcea Therapeutics Business Overview
11.8.3 Akcea Therapeutics Gene Therapy Products and Services
11.8.4 Akcea Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.8.5 Akcea Therapeutics Gene Therapy SWOT Analysis
11.8.6 Akcea Therapeutics Recent Development
11.9 bluebird bio
11.9.1 bluebird bio Company Details
11.9.2 bluebird bio Business Overview
11.9.3 bluebird bio Gene Therapy Products and Services
11.9.4 bluebird bio Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.9.5 bluebird bio Gene Therapy SWOT Analysis
11.9.6 bluebird bio Recent Development
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Details
11.10.2 Sunway Biotech Business Overview
11.10.3 Sunway Biotech Gene Therapy Products and Services
11.10.4 Sunway Biotech Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.10.5 Sunway Biotech Gene Therapy SWOT Analysis
11.10.6 Sunway Biotech Recent Development
11.11 SIBIONO
11.11.1 SIBIONO Company Details
11.11.2 SIBIONO Business Overview
11.11.3 SIBIONO Gene Therapy Products and Services
11.11.4 SIBIONO Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.11.5 SIBIONO Recent Development
11.12 AnGes
11.12.1 AnGes Company Details
11.12.2 AnGes Business Overview
11.12.3 AnGes Gene Therapy Products and Services
11.12.4 AnGes Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.12.5 AnGes Recent Development
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Details
11.13.2 Orchard Therapeutics Business Overview
11.13.3 Orchard Therapeutics Gene Therapy Products and Services
11.13.4 Orchard Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.13.5 Orchard Therapeutics Recent Development
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Details
11.14.2 Human Stem Cells Institute Business Overview
11.14.3 Human Stem Cells Institute Gene Therapy Products and Services
11.14.4 Human Stem Cells Institute Gene Therapy Revenue in Gene Therapy Business (2018-2023)
11.14.5 Human Stem Cells Institute Recent Development
12 Gene Therapy Market Dynamics
12.1 Gene Therapy Industry Trends
12.2 Gene Therapy Market Drivers
12.3 Gene Therapy Market Challenges
12.4 Gene Therapy Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Figures
List of Tables
Table 1. Global Gene Therapy Market Size Growth Rate (CAGR) by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Viral Gene Therapy
Table 3. Key Players of Non-Viral Gene Therapy
Table 4. Global Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Gene Therapy Market Size (US$ Million) Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
Table 6. Global Gene Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 7. Global Gene Therapy Revenue Forecast by Region (2024-2029) & (US$ Million)
Table 8. Global Gene Therapy Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Table 9. Global Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 10. Global Gene Therapy Market Share by Players (2018-2023)
Table 11. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2022)
Table 12. Ranking of Global Top Gene Therapy Companies by Revenue (US$ Million) in 2022
Table 13. Global 5 Largest Players Market Share by Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 14. Global Key Players of Gene Therapy, Headquarters and Area Served
Table 15. Global Key Players of Gene Therapy, Product and Application
Table 16. Global Key Players of Gene Therapy, Date of Enter into This Industry
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Global Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 19. Global Gene Therapy Revenue Market Share by Type (2018-2023)
Table 20. Global Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 21. Global Gene Therapy Revenue Market Share by Type (2024-2029)
Table 22. Global Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Gene Therapy Revenue Market Share by Application (2018-2023)
Table 24. Global Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Gene Therapy Revenue Market Share by Application (2024-2029)
Table 26. North America Gene Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 27. North America Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 28. North America Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 29. North America Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 30. North America Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 31. North America Gene Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Gene Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 33. North America Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 34. Europe Gene Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 35. Europe Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 36. Europe Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 37. Europe Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 38. Europe Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 39. Europe Gene Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 40. Europe Gene Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 41. Europe Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 42. Asia Pacific Gene Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 43. Asia Pacific Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 44. Asia Pacific Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 45. Asia Pacific Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 46. Asia Pacific Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 47. Asia-Pacific Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 48. Asia Pacific Gene Therapy Revenue by Region (2018-2023) & (US$ Million)
Table 49. Asia Pacific Gene Therapy Revenue by Region (2024-2029) & (US$ Million)
Table 50. Latin America Gene Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 51. Latin America Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 52. Latin America Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 53. Latin America Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 54. Latin America Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 55. Latin America Gene Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 56. Latin America Gene Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 57. Latin America Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 58. Middle East and Africa Gene Therapy Revenue by Company (2021-2023) & (US$ Million)
Table 59. Middle East and Africa Gene Therapy Revenue by Type (2018-2023) & (US$ Million)
Table 60. Middle East and Africa Gene Therapy Revenue by Type (2024-2029) & (US$ Million)
Table 61. Middle East and Africa Gene Therapy Revenue by Application (2018-2023) & (US$ Million)
Table 62. Middle East and Africa Gene Therapy Revenue by Application (2024-2029) & (US$ Million)
Table 63. Middle East and Africa Gene Therapy Revenue Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 64. Middle East and Africa Gene Therapy Revenue by Country (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Gene Therapy Revenue by Country (2024-2029) & (US$ Million)
Table 66. Biogen Company Details
Table 67. Biogen Business Overview
Table 68. Biogen Gene Therapy Product and Services
Table 69. Biogen Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 70. Biogen Gene Therapy SWOT Analysis
Table 71. Biogen Recent Development
Table 72. Novartis Company Details
Table 73. Novartis Business Overview
Table 74. Novartis Gene Therapy Product and Services
Table 75. Novartis Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 76. Novartis Gene Therapy SWOT Analysis
Table 77. Novartis Recent Development
Table 78. Gilead Sciences Company Details
Table 79. Gilead Sciences Business Overview
Table 80. Gilead Sciences Gene Therapy Product and Services
Table 81. Gilead Sciences Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 82. Gilead Sciences Gene Therapy SWOT Analysis
Table 83. Gilead Sciences Recent Development
Table 84. Sarepta Therapeutics Company Details
Table 85. Sarepta Therapeutics Business Overview
Table 86. Sarepta Therapeutics Gene Therapy Product and Services
Table 87. Sarepta Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 88. Sarepta Therapeutics Gene Therapy SWOT Analysis
Table 89. Sarepta Therapeutics Recent Development
Table 90. Alnylam Pharmaceuticals Company Details
Table 91. Alnylam Pharmaceuticals Business Overview
Table 92. Alnylam Pharmaceuticals Gene Therapy Product and Services
Table 93. Alnylam Pharmaceuticals Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 94. Alnylam Pharmaceuticals Gene Therapy SWOT Analysis
Table 95. Alnylam Pharmaceuticals Recent Development
Table 96. Amgen Company Details
Table 97. Amgen Business Overview
Table 98. Amgen Gene Therapy Product and Services
Table 99. Amgen Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 100. Amgen Gene Therapy SWOT Analysis
Table 101. Amgen Recent Development
Table 102. Spark Therapeutics Company Details
Table 103. Spark Therapeutics Business Overview
Table 104. Spark Therapeutics Gene Therapy Product and Services
Table 105. Spark Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 106. Spark Therapeutics Gene Therapy SWOT Analysis
Table 107. Spark Therapeutics Recent Development
Table 108. Akcea Therapeutics Company Details
Table 109. Akcea Therapeutics Business Overview
Table 110. Akcea Therapeutics Gene Therapy Product and Services
Table 111. Akcea Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 112. Akcea Therapeutics Gene Therapy SWOT Analysis
Table 113. Akcea Therapeutics Recent Development
Table 114. bluebird bio Company Details
Table 115. bluebird bio Business Overview
Table 116. bluebird bio Gene Therapy Product and Services
Table 117. bluebird bio Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 118. bluebird bio Gene Therapy SWOT Analysis
Table 119. bluebird bio Recent Development
Table 120. Sunway Biotech Company Details
Table 121. Sunway Biotech Business Overview
Table 122. Sunway Biotech Gene Therapy Product and Services
Table 123. Sunway Biotech Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 124. Sunway Biotech Gene Therapy SWOT Analysis
Table 125. Sunway Biotech Recent Development
Table 126. SIBIONO Company Details
Table 127. SIBIONO Business Overview
Table 128. SIBIONO Gene Therapy Product and Services
Table 129. SIBIONO Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 130. SIBIONO Recent Development
Table 131. AnGes Company Details
Table 132. AnGes Business Overview
Table 133. AnGes Gene Therapy Product and Services
Table 134. AnGes Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 135. AnGes Recent Development
Table 136. Orchard Therapeutics Company Details
Table 137. Orchard Therapeutics Business Overview
Table 138. Orchard Therapeutics Gene Therapy Product and Services
Table 139. Orchard Therapeutics Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 140. Orchard Therapeutics Recent Development
Table 141. Human Stem Cells Institute Company Details
Table 142. Human Stem Cells Institute Business Overview
Table 143. Human Stem Cells Institute Gene Therapy Product and Services
Table 144. Human Stem Cells Institute Gene Therapy Revenue in Gene Therapy Business (2018-2023) & (US$ Million)
Table 145. Human Stem Cells Institute Recent Development
Table 146. Gene Therapy Market Trends
Table 147. Gene Therapy Market Drivers
Table 148. Gene Therapy Market Challenges
Table 149. Gene Therapy Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Gene Therapy Product Picture
Figure 2. Global Gene Therapy Market Size by Type (US$ Million): 2018 VS 2022 VS 2029
Figure 3. Global Gene Therapy Market Share by Type: 2022 VS 2029
Figure 4. Viral Gene Therapy Features
Figure 5. Non-Viral Gene Therapy Features
Figure 6. Global Gene Therapy Market Size by Application (US$ Million): 2018 VS 2022 VS 2029
Figure 7. Global Gene Therapy Market Share by Application: 2022 VS 2029
Figure 8. Neurological Diseases
Figure 9. Cancer
Figure 10. Other
Figure 11. Gene Therapy Report Years Considered
Figure 12. Global Gene Therapy Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Gene Therapy Market Size 2018-2029 (US$ Million)
Figure 14. Global Gene Therapy Market Size Market Share by Region: 2022 VS 2029
Figure 15. Global Gene Therapy Revenue Market Share by Region in 2018 VS 2022
Figure 16. Global Gene Therapy Revenue Market Share Forecast by Region (2024-2029)
Figure 17. Global Top 10 Gene Therapy Countries Ranking by Market Size (US$ Million) in 2022
Figure 18. Global Gene Therapy Market Size of Top 10 Countries, 2018 VS 2022 VS 2029, (US$ Million)
Figure 19. Global Gene Therapy Market Share by Players in 2022
Figure 20. Global Top Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Gene Therapy Revenue in 2022
Figure 22. North America Gene Therapy Revenue Market Share by Company in 2022
Figure 23. North America Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 24. North America Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 25. North America Gene Therapy Revenue Share by Country (2018-2029)
Figure 26. U.S. Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 27. Canada Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 28. Europe Gene Therapy Revenue Market Share by Company in 2022
Figure 29. Europe Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 30. Europe Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 31. Europe Gene Therapy Revenue Share by Country (2018-2029)
Figure 32. Germany Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 33. France Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 34. U.K. Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 35. Italy Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 36. Russia Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Gene Therapy Revenue Market Share by Company in 2022
Figure 38. Asia Pacific Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 39. Asia Pacific Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 40. Asia Pacific Gene Therapy Revenue Share by Region (2018-2029)
Figure 41. China Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 42. Japan Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 43. South Korea Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 44. India Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 45. Australia Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 46. China Taiwan Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 47. Indonesia Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 48. Thailand Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 49. Malaysia Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 50. Latin America Gene Therapy Revenue Market Share by Company in 2022
Figure 51. Latin America Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 52. Latin America Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 53. Latin America Gene Therapy Revenue Share by Country (2018-2029)
Figure 54. Mexico Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 55. Brazil Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 56. Argentina Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 57. Middle East and Africa Gene Therapy Revenue Market Share by Company in 2022
Figure 58. Middle East and Africa Gene Therapy Revenue Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Gene Therapy Revenue Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Gene Therapy Revenue Share by Country (2018-2029)
Figure 61. Turkey Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 62. Saudi Arabia Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 63. UAE Gene Therapy Revenue (2018-2029) & (US$ Million)
Figure 64. Biogen Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 65. Novartis Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 66. Gilead Sciences Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 67. Sarepta Therapeutics Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 68. Alnylam Pharmaceuticals Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 69. Amgen Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 70. Spark Therapeutics Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 71. Akcea Therapeutics Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 72. bluebird bio Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 73. Sunway Biotech Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 74. SIBIONO Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 75. AnGes Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 76. Orchard Therapeutics Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 77. Human Stem Cells Institute Revenue Growth Rate in Gene Therapy Business (2018-2023)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
